Work

Abstract 2955: Preclinical development of TJ101, a potent bispecific ADC targeting EGFR and B7-H3 for the treatment of solid cancers

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-2955

Authors: Li Qi, Shugaku Takeda, Yangxin Zhang, Mao Huang, Dongdong Zhou, Yanli Mao, Zhaoyuan Chen, Siyi Hu

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409689434

Cites:

Cited by: 3

Related to: 10